DOI QR코드

DOI QR Code

A study on the clinical usefulness, validity, and test-retest reliability of the Spirokit, a device that combines the pulmonary function test and respiratory muscle strength test

  • Kim, Byeong-Soo (Department of Physical Therapy, Graduate School, Daejeon University) ;
  • Lee, Myung-Mo (Department of Physical Therapy, Daejeon University)
  • Received : 2020.05.28
  • Accepted : 2020.06.19
  • Published : 2020.06.30

Abstract

Objective: This study was conducted to identify the clinical usefulness, validity, and reliability of the Spirokit, a device that combines the pulmonary function test (PFT) and respiratory muscle strength (RMS) test. Design: Cross-sectional study. Methods: Forty young adults (male: 23, female: 17) participated in a PFT and a RMS test. The concurrent validity for pulmonary function was assessed by comparing data obtained from MicroQuark and the Spirokit and the agreements between the MicroRPM and the Spirokit for RMS were compared. The test-retest reliability of the Spirokit was determined by comparing data obtained from the first and second sessions. The test and retest were performed at the same time after one day for the PFT and RMS test. Validity was estimated using intraclass correlation coefficients (ICCs), and by calculating 95% limits of agreement (LoA). To estimate interrater reliability, ICCs were calculated. Results: The Spirokit showed a high agreement intra class coefficient (ICC [2, 1]): 0.978-0.999, 95% limits of agreements (95% LOA): -0.798 to 0.847 with MicroQuark. It also showed a high level of concordance ICC (2, 1): 0.992 to 0.993, 95% LOA: -9.313 to 11.169 with MicroRPM. The test-retest reliability of the Spirokit was analyzed using ICC (2, 1), and showed a high level of reliability (ICC [2,1]=0.960 to 0.998). Standard error of measurement % (SEM%) was 0.12% to 3.39%, and minimum detectable change% (MDC%) was 0.02% to 3.79%, indicating high level of reliability. Conclusions: The Spirokit is a device with high validity and reliability that can be used to simultaneously measure PFT and RMS tests.

Keywords

References

  1. Rotar AM, van den Berg MJ, Kringos DS, Klazinga NS. Reporting and use of the OECD Health Care Quality Indicators at national and regional level in 15 countries. Int J Qual Health Care 2016;28:398-404. https://doi.org/10.1093/intqhc/mzw027
  2. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27:397-412. https://doi.org/10.1183/09031936.06.00025805
  3. Jung EK. Chronic disease status and issues. Cheongju: Korea Centers for Disease Control and Prevention; 2019.
  4. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009;374:733-43. https://doi.org/10.1016/S0140-6736(09)61303-9
  5. World Health Organization. Asthma [Internet]. Geneva: World Health Organization, 2020 [cited 2020 Jun 2]. Available from: https://www.who.int/news-room/q-a-detail/asthma.
  6. Koh YJ, Kim SD, Park SY, Jang SK. Childrens' health risk assessment on indoor hazardous air pollutants of preschool facility. J Environ Health Sci 2009;35:78-85.
  7. Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006;61:663-70. https://doi.org/10.1136/thx.2005.055699
  8. Gold WM, Koth LL. Pulmonary function testing. In: Broaddus VC, Mason RJ, Ernst JD, King TE, Lazarus SC, Murray JF, et al., editors. Murray and Nadel's textbook of respiratory medicine. 6th ed. Philadelphia (PA): W.B. Saunders; 2016. p. 407-435.e18.
  9. Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med 2019;200:e70-88. https://doi.org/10.1164/rccm.201908-1590ST
  10. Hanayama K, Ishikawa Y, Bach JR. Amyotrophic lateral sclerosis. Successful treatment of mucous plugging by mechanical insufflation-exsufflation. Am J Phys Med Rehabil 1997;76:338-9. https://doi.org/10.1097/00002060-199707000-00017
  11. Teixeira-Salmela LF, Olney SJ, Nadeau S, Brouwer B. Muscle strengthening and physical conditioning to reduce impairment and disability in chronic stroke survivors. Arch Phys Med Rehabil 1999;80:1211-8. https://doi.org/10.1016/S0003-9993(99)90018-7
  12. Teixeira-Salmela LF, Parreira VF, Britto RR, Brant TC, Inacio EP, Alcantara TO, et al. Respiratory pressures and thoracoabdominal motion in community-dwelling chronic stroke survivors. Arch Phys Med Rehabil 2005;86:1974-8. https://doi.org/10.1016/j.apmr.2005.03.035
  13. Decramer M, Demedts M, Rochette F, Billiet L. Maximal transrespiratory pressures in obstructive lung disease. Bull Eur Physiopathol Respir 1980;16:479-90.
  14. Agarwal V, Ramachandran N. Design and development of a low-cost spirometer with an embedded web server. Int J Biomed Eng Technol 2008;1:439-52. https://doi.org/10.1504/IJBET.2008.020072
  15. Ovechkin A, Vitaz T, de Paleville DT, Aslan S, McKay W. Evaluation of respiratory muscle activation in individuals with chronic spinal cord injury. Respir Physiol Neurobiol 2010;173:171-8. https://doi.org/10.1016/j.resp.2010.07.013
  16. Ministry of SMEs and Startups. Bio health technology roadmap for SME 2020-2022 [Internet]. Daejeon: Ministry of SMEs and Startups, 2020 [cited 2020 Jun 2]. Available from: http://smroadmap.smtech.go.kr/0201/view/m_code/A140/s_code/A17/idx/2505.
  17. Shmulewitz A, Langer R, Patton J. Convergence in biomedical technology. Nat Biotechnol 2006;24:277.
  18. Oh YM, Hong SB, Shim TS, Lim CM, Koh Y, Kim WS, et al. Effect of a new spirometric reference equation on the interpretation of spirometric patterns and disease severity. Tuberc Respir Dis 2006;60:215-20. https://doi.org/10.4046/trd.2006.60.2.215
  19. Balasubramaniam M, Sivapalan K, Thuvarathipan R. Lung function parameters of healthy Sri Lankan Tamil young adults. Ceylon Med J 2014;59:49-53. https://doi.org/10.4038/cmj.v59i2.7063
  20. Melbye H, Medbo A, Crockett A. The FEV1/FEV6 ratio is a good substitute for the FEV1/FVC ratio in the elderly. Prim Care Respir J 2006;15:294-8. https://doi.org/10.1016/j.pcrj.2006.07.002
  21. Dassios T, Katelari A, Doudounakis S, Dimitriou G. Comparison of two methods of measurement of maximal respiratory pressures in health and cystic fibrosis. J Biomed Sci Eng 2013;6:43-8. https://doi.org/10.4236/jbise.2013.68A2006
  22. Badr C, Elkins MR, Ellis ER. The effect of body position on maximal expiratory pressure and flow. Aust J Physiother 2002;48:95-102. https://doi.org/10.1016/S0004-9514(14)60203-8
  23. Portney LG. Foundations of clinical research: applications to evidence-based practice. 4th ed. Philadelphia (PA): FA Davis; 2020.
  24. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Int J Nurs Stud 2010;47:931-6. https://doi.org/10.1016/j.ijnurstu.2009.10.001
  25. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12-9. https://doi.org/10.1037/0022-006X.59.1.12
  26. COSMED. MicroQuark brochure [Internet]. Rome: COSMED, 2020 [cited 2020 Jun 2]. Available from: https://www.cosmed.com/hires/microQuark_flyerbrochure_A4_C09061-02-93_EN_web.pdf.
  27. CareFusion. The manual of MicroRPM. Basingstoke: CareFusion; 2014.